Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells
Clinical Cancer Research (2004) - Comments
pubmed: 15073106  issn: 1078-0432  doi: 10.1158/1078-0432.ccr-1183-3  issn: 1557-3265 

Mark S Duxbury, Hiromichi Ito, Michael J Zinner, Stanley W Ashley, Edward E Whang